[Interferon therapy in chronic hepatitis B and delta infection in children].
Nisevich
N I
NI
Uchaĭkin
V F
VF
Sokolova
N V
NV
Kuznetsov
V P
VP
Syr'eva
T N
TN
Cherednichenko
T V
TV
Kaganov
B S
BS
Moleva
T P
TP
Iusuf-zade
A A
AA
Guseva
L N
LN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000276:immunology / Q000628:therapy*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D003699:Hepatitis D / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007223:Infant; D016898:Interferon-alpha / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use; D013949:Thymus Extracts / Q000627:therapeutic use; D013997:Time Factors
D000276:Adjuvants, Immunologic; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Interferonoterapiia pri khronicheskom gepatite B i del'ta u deteĭ.